Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Am Acad Dermatol. 2017 Nov 13;78(4):663–672.e3. doi: 10.1016/j.jaad.2017.11.026

Table 1. Summary of Study Characteristics.

Reference Country, publication year Dates of data collection Study design Diagnosis* No of cases No of deaths Age (range, mean, or percentage in years) Percent male (%)
Studies included in meta-analysis
Eisemann et al [44] Germany, 2016 1997-2011 Retrospective cohort using national registries BCC 380030 101848** 68.9 50.8
SCC 92108 35185** 75.6 58.1
Jensen et al 2008†† [25] Denmark, 2008 1978-2001 Retrospective cohort using national registries BCC 82837 28758 58.3% >65 48
SCC 13453 6998 78.3% >65 60.6
Rees et al [29] USA, 2015 1993-2009 Retrospective cohort from previous case-control study BCC 1363 169 -- 50.1
SCC 880 189 61.4
Hollestein et al [6] Netherlands, 2012 1989-2008 Retrospective cohort using national registries SCC 69408 31903 73.6 59.9
Studies not included in meta-analysis
Brondum-Jacobsen et al†† [27] Denmark, 2013 1980-2006 Retrospective cohort using national registries KC 129206 -- >40 49
Clayman et al [47] USA, 2005 1996-2001 Prospective cohort SCC 210 52 34-94.7 89.1
Jensen et al 2010†† [34] Denmark, 2010 1990-2005 Retrospective cohort using national registries BCC 72295 -- 8-106 47
SCC 11601 -- -- 65
Kahn et al [28] USA, 1998 1982-1994 Prospective cohort KC 35062 -- M 61.5 (SD 9.1); F 60.5 (SD 10.1) 54.5
Karjalainen et al [23] Finland, 1989 1967-1982 Retrospective cohort using national registries BCC 23975 -- M=64.1; F=66.9. 42.3
SCC 2927 -- M=68.5; F=72.0
Robsahm et al [39] Norway, 2015 1963-2011 Retrospective cohort using national registries SCC 30818 -- -- 55.4
Teppo et al [45] Finland, 1999 1985-1994 Retrospective cohort using national registries SCC -- -- -- --
Talback et al [46] Sweden, 2004 1960-1998 Retrospective cohort using national registries SCC -- -- -- --
*

BCC= basal cell carcinoma; SCC= squamous cell carcinoma; KC= keratinocyte carcinoma (BCC and SCC grouped together in publication)

**

Number of deaths was calculated using percentage of surviving patients presented in the article

Included ‘malignant skin cancer excluding melanoma’ in a cancer registry that does not collect BCC data

††

Jensen 2008, Brondum-Jacobsen, and Jensen 2010 have overlapping study populations. Brondum-Jacobsen was included qualitatively because it provides a combined BCC/SCC estimate. Jensen 2010 was included qualitatively because it adjusted extensively for covariates